PROM1 and glioblastoma: Genetically divergent GBM cell populations might have evolved from GSCs of different origins that expressed variable patterns of stem-cell markers, such as CD133, CD15, A2B5, and CD44, due to which they might harbor different tumorigenic potential [2].